Literature DB >> 23160795

Personalized decision support in type 2 diabetes mellitus: current evidence and future directions.

Michael J Wilkinson1, Aviva G Nathan, Elbert S Huang.   

Abstract

The management of type 2 diabetes comprises a complex series of medical decisions regarding goals of care, self-care behaviors, and medical treatments. The quality of these medical decisions is critical to determining whether an individual diabetes patient is treated appropriately, overtreated, or undertreated. It is hypothesized that the quality of these medical decisions can be enhanced by personalized decision support tools that summarize patient clinical characteristics, treatment preferences, and ancillary data at the point of care. We describe the current state of personalized diabetes decision support on the basis of 13 recently described tools. Three tools provided support for personalized decisions based on preferences, while the remaining 10 provided support for treatment decisions designed to achieve standard diabetes goals. For the tools that supported personalized decisions, patient participation in medical decisions improved. Future decision support tools must be designed to account for both clinical characteristics and patient preferences.

Entities:  

Mesh:

Year:  2013        PMID: 23160795      PMCID: PMC3593795          DOI: 10.1007/s11892-012-0348-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  25 in total

1.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

2.  Development and validation of a computer application to aid the physician's decision-making process at the start of and during treatment with insulin in type 2 diabetes: a randomized and controlled trial.

Authors:  Antonio Sáenz; Miguel Brito; Ignacio Morón; Amalia Torralba; Elena García-Sanz; Jesus Redondo
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

3.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

4.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

5.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

6.  Development of life-expectancy tables for people with type 2 diabetes.

Authors:  Jose Leal; Alastair M Gray; Philip M Clarke
Journal:  Eur Heart J       Date:  2008-12-24       Impact factor: 29.983

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  A shared decision-making primary care intervention for type 2 diabetes.

Authors:  William Corser; Margaret Holmes-Rovner; Catherine Lein; Ved Gossain
Journal:  Diabetes Educ       Date:  2007 Jul-Aug       Impact factor: 2.140

9.  A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial.

Authors:  Michael R Nannenga; Victor M Montori; Audrey J Weymiller; Steven A Smith; Teresa J H Christianson; Sandra C Bryant; Amiram Gafni; Cathy Charles; Rebecca J Mullan; Lesley A Jones; Enrique R Bolona; Gordon H Guyatt
Journal:  Health Expect       Date:  2009-03       Impact factor: 3.377

10.  Combined task delegation, computerized decision support, and feedback improve cardiovascular risk for type 2 diabetic patients: a cluster randomized trial in primary care.

Authors:  Frits G W Cleveringa; Kees J Gorter; Maureen van den Donk; Guy E H M Rutten
Journal:  Diabetes Care       Date:  2008-09-16       Impact factor: 19.112

View more
  14 in total

1.  Participatory approach to the development of a knowledge base for problem-solving in diabetes self-management.

Authors:  Heather J Cole-Lewis; Arlene M Smaldone; Patricia R Davidson; Rita Kukafka; Jonathan N Tobin; Andrea Cassells; Elizabeth D Mynatt; George Hripcsak; Lena Mamykina
Journal:  Int J Med Inform       Date:  2015-08-08       Impact factor: 4.046

2.  Designing Decision-Support Technologies for Patient-Generated Data in Type 1 Diabetes.

Authors:  Si Sun; Kaitlin L Costello
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

Review 3.  New approaches to providing individualized diabetes care in the 21st century.

Authors:  Priscilla W Powell; Sarah D Corathers; Jennifer Raymond; Randi Streisand
Journal:  Curr Diabetes Rev       Date:  2015

4.  Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support.

Authors:  Sung Eun Choi; Seth A Berkowitz; John S Yudkin; Huseyin Naci; Sanjay Basu
Journal:  Med Decis Making       Date:  2019-02-15       Impact factor: 2.583

5.  A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.

Authors:  F Javier Ampudia-Blasco; Pierre Yves Benhamou; Guillaume Charpentier; Agostino Consoli; Michaela Diamant; Baptist Gallwitz; Kamlesh Khunti; Chantal Mathieu; Martin Ridderstråle; Jochen Seufert; Cees Tack; Tina Vilsbøll; Tra-Mi Phan; Herman Stoevelaar
Journal:  Diabetes Technol Ther       Date:  2014-10-27       Impact factor: 6.118

6.  Effectiveness of Technologically Enhanced Peer Support in Improving Glycemic Management Among Predominantly African American, Low-Income Adults With Diabetes.

Authors:  Michele Heisler; Hwajung Choi; Rebecca Mase; Judith A Long; Pamela J Reeves
Journal:  Diabetes Educ       Date:  2019-04-26       Impact factor: 2.140

7.  Comparison of community health worker-led diabetes medication decision-making support for low-income Latino and African American adults with diabetes using e-health tools versus print materials: a randomized, controlled trial.

Authors:  Michele Heisler; Hwajung Choi; Gloria Palmisano; Rebecca Mase; Caroline Richardson; Angela Fagerlin; Victor M Montori; Michael Spencer; Laurence C An
Journal:  Ann Intern Med       Date:  2014-11-18       Impact factor: 25.391

Review 8.  Management of diabetes mellitus in older people with comorbidities.

Authors:  Elbert S Huang
Journal:  BMJ       Date:  2016-06-15

9.  Translating What Works: A New Approach to Improve Diabetes Management.

Authors:  Lawrence S Phillips; Diana Barb; Chun Yong; Anne M Tomolo; Sandra L Jackson; Darin E Olson; Mary K Rhee; Ingrid M Duva; Qing He; Qi Long
Journal:  J Diabetes Sci Technol       Date:  2015-03-09

10.  Shared decision making in type 2 diabetes with a support decision tool that takes into account clinical factors, the intensity of treatment and patient preferences: design of a cluster randomised (OPTIMAL) trial.

Authors:  Henk den Ouden; Rimke C Vos; Carla Reidsma; Guy E H M Rutten
Journal:  BMC Fam Pract       Date:  2015-02-27       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.